India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’

Case filed in 2022 by patient unable to afford medicine leads to cap on drug prices for millions who face ruin if diagnosed

The Indian government has moved to reduce the price of cancer drugs after a retired bank clerk took her case to the supreme court.

From next month, 137 cancer drugs in India will be cheaper as the government tries to tackle the tragedy of poorer patients either forgoing treatment, selling land or falling into debt to meet the high cost of some medicines, which are making large profits for hospitals and pharmacists.